NDA 3402, held by Parke Davis. Vasopressin Tannate.
As of Nov 13, 2026, NDA 3402 (Pitressin Tannate), held by Parke Davis, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Pitressin Tannate5PRESSOR UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** ยท injectable;injection | Vasopressin Tannate | DiscontinuedReference drug |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
